✦ LIBER ✦

Imaging nigral pathology and clinical progression in Parkinson's disease

✍ Scribed by Guangwei Du; Mechelle M. Lewis; Suman Sen; Jianli Wang; Michele L. Shaffer; Martin Styner; Qing X. Yang; Xuemei Huang

Book ID: 115560034
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 585 KB
Volume: 27
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.25182

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The progression of pathology in Parkinso

The progression of pathology in Parkinson's disease

✍ Glenda Margaret Halliday; Heather McCann 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

Nigral pathology and parkinsonian signs

Nigral pathology and parkinsonian signs in elders without Parkinson disease

✍ Aron S. Buchman; Joshua M. Shulman; Sukriti Nag; Sue E. Leurgans; Steven E. Arno 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 958 KB

## Abstract ## Objective: Motor symptoms such as mild parkinsonian signs are common in older persons, but little is known about their underlying neuropathology. We tested the hypothesis that nigral pathology is related to parkinsonism in older persons without Parkinson disease (PD). ## Methods:

Pain sensitivity and clinical progressio

Pain sensitivity and clinical progression in Parkinson's disease

✍ Veit Mylius; Juliane Brebbermann; Helena Dohmann; Isabel Engau; Wolfgang H. Oert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

## Abstract Pain sensitivity in Parkinson's disease is known to be altered in an L‐dopa‐dependent manner with increased spinal nociception and experimental pain perception in the medication‐defined “off” state. As Parkinson's disease‐related pain can be an early symptom in Parkinson's disease, the

Nigral degeneration in Parkinson's disea

Nigral degeneration in Parkinson's disease in relation to clinical features

✍ J. O. Rinne 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

Clinical measures of progression in Park

Clinical measures of progression in Parkinson's disease

✍ Werner Poewe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract Despite all recent advances in symptomatic therapy Parkinson's disease (PD) continues to be a relentlessly progressive neurodegenerative disorder. Therefore therapies that will slow or hold disease progression are a major medical unmet need in PD. Clinical measures of disease progressio

Milestones in Parkinson's disease—Clinic

Milestones in Parkinson's disease—Clinical and pathologic features

✍ Glenda Halliday; Andrew Lees; Matthew Stern 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB 👁 1 views

## Abstract The identification of the widespread deposition of fibrillized α‐synuclein in Lewy bodies and Lewy neurites in the brains of patients with Parkinson's disease in 1997 has had a profound impact on how the disease is now conceptualized. The previous focus on the loss of the dopaminergic n